Geode Capital Management
FLNA

Geode Capital Management’s Filana Therapeutics FLNA Stock Holding History

Geode Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
596,242
+50,273
+9% +$103K ﹤0.01% 3349
2025
Q4 		$1.08M Buy
545,969
+8,068
+1% +$25.8K ﹤0.01% 3355
2025
Q3 		$1.57M Buy
537,901
+15,022
+3% +$34.5K ﹤0.01% 3266
2025
Q2 		$947K Sell
522,879
-503,720
-49% -$896K ﹤0.01% 3341
2025
Q1 		$1.54M Buy
1,026,599
+19,604
+2% +$49.5K ﹤0.01% 3145
2024
Q4 		$2.38M Sell
1,006,995
-1,598
-0.2% -$28.1K ﹤0.01% 3067
2024
Q3 		$29.7M Buy
1,008,593
+41,289
+4% +$951K ﹤0.01% 1760
2024
Q2 		$11.9M Buy
967,304
+65,464
+7% +$1.38M ﹤0.01% 2218
2024
Q1 		$18.3M Buy
901,840
+27,844
+3% +$642K ﹤0.01% 1973
2023
Q4 		$19.7M Buy
873,996
+43,746
+5% +$924K ﹤0.01% 1933
2023
Q3 		$13.8M Buy
830,250
+26,944
+3% +$534K ﹤0.01% 2057
2023
Q2 		$19.7M Buy
803,306
+44,350
+6% +$1.07M ﹤0.01% 1865
2023
Q1 		$18.3M Buy
758,956
+50,164
+7% +$1.39M ﹤0.01% 1865
2022
Q4 		$20.9M Buy
708,792
+23,941
+3% +$860K ﹤0.01% 1743
2022
Q3 		$28.6M Buy
684,851
+11,309
+2% +$305K ﹤0.01% 1490
2022
Q2 		$18.9M Buy
673,542
+27,695
+4% +$699K ﹤0.01% 1809
2022
Q1 		$24M Buy
645,847
+9,423
+1% +$399K ﹤0.01% 1776
2021
Q4 		$27.8M Sell
636,424
-2,049
-0.3% -$107K ﹤0.01% 1734
2021
Q3 		$39.6M Buy
638,473
+6,292
+1% +$525K 0.01% 1459
2021
Q2 		$54M Buy
632,181
+70,504
+13% +$3.78M 0.01% 1237
2021
Q1 		$25.2M Buy
561,677
+103,857
+23% +$4.08M ﹤0.01% 1726
2020
Q4 		$3.12M Buy
457,820
+152,233
+50% +$1.36M ﹤0.01% 2847
2020
Q3 		$3.52M Buy
305,587
+45,008
+17% +$203K ﹤0.01% 2586
2020
Q2 		$802K Buy
260,579
+149,082
+134% +$676K ﹤0.01% 3214
2020
Q1 		$458K Sell
111,497
-32,754
-23% -$217K ﹤0.01% 3301
2019
Q4 		$750K Buy
144,251
+69,519
+93% +$120K ﹤0.01% 3370
2019
Q3 		$89K Hold
74,732
– – ﹤0.01% 3973
2019
Q2 		$90K Buy
74,732
+8,664
+13% +$9.83K ﹤0.01% 3986
2019
Q1 		$85K Hold
66,068
– – ﹤0.01% 3930
2018
Q4 		$56K Buy
66,068
+28,314
+75% +$32.5K ﹤0.01% 3971
2018
Q3 		$38K Hold
37,754
– – ﹤0.01% 4051
2018
Q2 		$77K Buy
37,754
+9,535
+34% +$81.8K ﹤0.01% 3924
2018
Q1 		$200K Hold
28,219
– – ﹤0.01% 3689
2017
Q4 		$112K Hold
28,219
– – ﹤0.01% 3797
2017
Q3 		$114K Hold
28,219
– – ﹤0.01% 3800
2017
Q2 		$116K Sell
28,219
-1,095
-4% -$5.17K ﹤0.01% 3812
2017
Q1 		$183K Buy
29,314
+149
+0.5% +$676 ﹤0.01% 3690
2016
Q4 		$116K Buy
29,165
+100
+0.3% +$464 ﹤0.01% 3762
2016
Q3 		$203K Buy
29,065
+25
+0.1% +$414 ﹤0.01% 3601
2016
Q2 		$445K Hold
29,040
– – ﹤0.01% 3263
2016
Q1 		$453 Sell
29,040
-25
-0.1% -$323 ﹤0.01% 3282
2015
Q4 		$356K Buy
29,065
+49
+0.2% +$648 ﹤0.01% 3428
2015
Q3 		$371K Buy
29,016
+50
+0.2% +$631 ﹤0.01% 3371
2015
Q2 		$350K Sell
28,966
-2,980
-9% -$40.8K ﹤0.01% 3361
2015
Q1 		$422K Buy
31,946
+703
+2% +$9.49K ﹤0.01% 3264
2014
Q4 		$443K Buy
31,243
+62
+0.2% +$1.07K ﹤0.01% 3248
2014
Q3 		$853K Buy
31,181
+2,544
+9% +$77.3K ﹤0.01% 2872
2014
Q2 		$1.15M Buy
28,637
+3,866
+16% +$143K ﹤0.01% 2717
2014
Q1 		$953K Buy
24,771
+759
+3% +$26.8K ﹤0.01% 2822
2013
Q4 		$816K Buy
24,012
+41
+0.2% +$1.09K ﹤0.01% 2838
2013
Q3 		$456K Buy
23,971
+4,371
+22% +$76.4K ﹤0.01% 2996
2013
Q2 		$303K Buy
+19,600
New +$414K ﹤0.01% 3079

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management's FLNA Position: Q1 2026 in Review

Geode Capital Management increased its Filana Therapeutics (FLNA) stake by 9.2% in Q1 2026, buying an estimated $103K and bringing the position to 596,242 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Geode Capital Management first reported a position in FLNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $54M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Geode Capital Management held 596,242 shares of Filana Therapeutics worth $1.01M as of Q1 2026.
  • Geode Capital Management bought 50,273 Filana Therapeutics shares in Q1 2026, an estimated $103K.
  • Filana Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3349 holding.
  • Geode Capital Management first reported a position in Filana Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Filana Therapeutics position peaked at $54M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.